AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ALL
ACCE-researched

Allstate Corporation (The) Common Stock (ALL) fair value

Financial Services · Insurance - Property & Casualty · NYSE · United States
$253.19-2.28%
Market cap $64.0BNext earnings 2026-11-04Updated Oct 18, 2026
Add earnings to calendarGoogle
Our verdict
Trades 41% below our fair value
Price
$253.19
Model fair valueConfidence: medium
$427
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as an insurer: P/E comparison and Dividend discount.
ACCE opinionAllstate Corporation (The) Common Stock (ALL)
Fair value (2 models)
Not available
ACCE price target
$254
Rating
Not rated
Horizon
12 months
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $280 since 9 May 2026, 00:00 CEST.
Price used: $253 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
84
out of 100
Analysts
44% buy
25 covering
P/E
5.1x
forward 9.0x
1-year return
+30.2%
Dividend yield
1.67%

Allstate Corporation (The) Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Allstate writes personal auto and homeowners policies under the Allstate brand, with Esurance, National General and Allstate Protection Plans (device and vehicle warranty contracts) adding reach across the U.S. personal lines market. Its edge is scale in claims and pricing: a 46.1% return on equity on a 60.6 billion dollar market cap is unusual for a property and casualty carrier and points to disciplined underwriting and a profitable mix shift toward higher-margin products. Near term, the stock trades at 4.7 times trailing earnings and 8.3 times forward earnings, which implies the market is pricing in margin normalization after a hard stretch for auto insurers. Revenue growth of 11.8% alongside a 22.8% operating margin makes the case that current earnings may be holding up better than that multiple suggests, though reserve adequacy and catastrophe losses are the figures to test before anything else. Worth a deeper look to see whether the forward earnings path is as durable as the headline ratios imply.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Insider selling concentration
    Last 10 disclosed transactions show $14.87M in sales, zero buys. Suggests insiders may view current valuation as stretched relative to intrinsic value.
  • moderate
    Quality score lag
    ACCE Quality subscores 85/100, but Momentum component at 63/100 trails other pillars. Suggests recent momentum may not be sustainable.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Allstate trades at 4.6x trailing earnings with a 26.1% free cash flow yield, suggesting deep undervaluation.
  • The company generated 46.1% return on equity and 22.1% return on invested capital, well above cost of capital.
  • Revenue grew 11.8% year over year with a 19.0% net margin while returning capital through 1.2% share buybacks.
Why it could disappoint
  • Analyst consensus targets 17.9% upside, implying limited margin of safety at current valuations.
  • Latest earnings beat of 56.1% may reflect easier comparisons rather than sustainable operational improvement.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ALL's valuation models land
Price
$253.19
Model fair valueConfidence: medium
$427
Model
Fair value
Upside
Dividend discount
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed44% buy · 25 covering analysts
● Strong buy 9● Buy 2● Hold 10● Sell 2● Strong sell 2
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
0 buys · 1 sell
Since Aug 12, 2026, 1 member
Average delay
0 days
From trade to public filing
Full trade list on ProDo politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+2.1%
1 month
+12.2%
3 months
-2.6%
6 months
+18.9%
YTD
+21.6%
1 year
+30.2%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
18 Oct 2026, 00:00 CESTACCE price target$254$280$248
4 Oct 2026, 00:00 CESTFair value$373$378$224
30 Sept 2026, 00:00 CESTFair value$378$293$228
26 Sept 2026, 00:00 CESTFair value$293$298$227
19 Sept 2026, 00:00 CESTFair value$298$301$252
12 Sept 2026, 00:00 CESTFair value$301$317$252
23 Aug 2026, 00:00 CESTFair value$317$321$256
21 Aug 2026, 00:00 CESTFair value$321$427$261
19 Aug 2026, 00:00 CESTFair value$427$485$259
13 Aug 2026, 00:00 CESTFair value$485$466$266

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ALL page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value83Quality85Momentum90Total84
Valuation
Trailing P/E
5.1x
Forward P/E
9.0x
PEG
0.08
P/B
1.83x
EV / Revenue
1.0x
Book value/sh
$124.79
Enterprise value
$65.7B
Profitability
ROE
46.1%
FCF yield
15.57%
ROIC
22.1%
Health and risk
Debt / equity
0.24
Dividend yield
1.67%
Beta
0.14

Price

+31.1% · 1Y

Ask anything about ALL

Answered from Allstate Corporation (The) Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 5.1x5.1xhigh 21.5x
ROEbetter than 100% of peers
low 14%46%high 46%
Div yieldbetter than 50% of peers
low 0.2%1.7%high 2.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ALL Allstate Corporation (The) Common Stock$253.19--5.1x46.1%8584
TRV The Travelers Companies Inc. Common Stock$405.44$4398% below10.5x27.5%8571
8725.T MS&AD Insurance Group Holdings, Inc.¥5205.00¥352748% above8.6x16.1%7279
8630.T Sompo Holdings, Inc.¥6994.00¥513836% above21.5x14.4%6480
FFH.TO Fairfax Financial Holdings LimitedC$2515.29C$27649% below8.8x16.5%7257
IFC.TO Intact FinancialC$267.37C$20133% above14.7x16.1%6757
PGR Progressive Corporation (The) Common Stock$229.62$2262% above11.5x33.2%7763

Sector report card

Where ALL ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Oct 12, 2026
    Allstate supports customers after Hurricane Isaias
  • PR Newswire•Oct 7, 2026
    Carriers Add Mobile Value for Policyholders with Personalized Savings Offers, Streamlined Coverage Tools and Enhanced Login Security
  • PR Newswire•Oct 6, 2026
    What is the Auto Lab at Allstate Claims University? How Allstate trains auto claims adjusters on modern vehicle damage
8 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 15
8-KCurrent reportPeriod 2026-10-15
View on SEC →
Oct 6
Form 4Insider transactionPeriod 2026-10-03
View on SEC →
Oct 6
Form 4Insider transactionPeriod 2026-10-03
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR